Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jul 26, 2026
Mohit Bansal's Stock Ratings
Wells Fargo Analyst
Mohit Bansal is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
10.3%
Smart Score
Overall Average Return Percentile
58th
Number of Ratings
220
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/17/2026 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | 13.79% | $175 → $200 | Maintains | Overweight | Get Alert | |
| 07/14/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | 12.26% | $265 → $285 | Maintains | Overweight | Get Alert | |
| 07/10/2026 | ABBV | Buy Now | AbbVie | $258.05 | 14.32% | $260 → $295 | Maintains | Overweight | Get Alert | |
| 07/08/2026 | MRK | Buy Now | Merck & Co | $130.41 | 15.03% | $145 → $150 | Maintains | Overweight | Get Alert | |
| 06/12/2026 | TVTX | Buy Now | Travere Therapeutics | $55.25 | 17.65% | $50 → $65 | Maintains | Overweight | Get Alert | |
| 05/18/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 6.71% | $800 → $700 | Maintains | Equal-Weight | Get Alert | |
| 05/14/2026 | MIST | Buy Now | Milestone Pharmaceuticals | $1.17 | 500.34% | $8 → $7 | Maintains | Overweight | Get Alert | |
| 05/06/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | 4.38% | $250 → $265 | Maintains | Overweight | Get Alert | |
| 05/06/2026 | TVTX | Buy Now | Travere Therapeutics | $55.25 | -9.5% | $40 → $50 | Maintains | Overweight | Get Alert | |
| 05/06/2026 | BNTX | Buy Now | BioNTech | $89.50 | 56.42% | $150 → $140 | Maintains | Overweight | Get Alert | |
| 05/01/2026 | MRK | Buy Now | Merck & Co | $130.41 | 11.19% | $150 → $145 | Maintains | Overweight | Get Alert | |
| 04/30/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 21.95% | $825 → $800 | Maintains | Equal-Weight | Get Alert | |
| 04/20/2026 | BIIB | Buy Now | Biogen | $201.80 | 23.89% | $200 → $250 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 03/12/2026 | MRK | Buy Now | Merck & Co | $130.41 | 15.03% | $135 → $150 | Maintains | Overweight | Get Alert | |
| 02/25/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | -1.52% | $235 → $250 | Maintains | Overweight | Get Alert | |
| 02/19/2026 | HALO | Buy Now | Halozyme Therapeutics | $82.00 | -8.54% | $65 → $75 | Maintains | Equal-Weight | Get Alert | |
| 02/19/2026 | AMGN | Buy Now | Amgen | $376.34 | -0.36% | $325 → $375 | Maintains | Equal-Weight | Get Alert | |
| 02/18/2026 | BMRN | Buy Now | BioMarin Pharmaceutical | $59.50 | 26.05% | $70 → $75 | Maintains | Overweight | Get Alert | |
| 02/13/2026 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | -0.44% | $180 → $175 | Maintains | Overweight | Get Alert | |
| 02/11/2026 | GILD | Buy Now | Gilead Sciences | $129.98 | 26.94% | $150 → $165 | Maintains | Overweight | Get Alert | |
| 02/09/2026 | BIIB | Buy Now | Biogen | $201.80 | -0.89% | $190 → $200 | Maintains | Equal-Weight | Get Alert | |
| 02/06/2026 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | -3.21% | $55 → $60 | Maintains | Equal-Weight | Get Alert | |
| 02/05/2026 | LLY | Buy Now | Eli Lilly and Co | $1.20K | 6.94% | $1200 → $1280 | Maintains | Overweight | Get Alert | |
| 02/04/2026 | MRK | Buy Now | Merck & Co | $130.41 | 3.52% | $125 → $135 | Maintains | Overweight | Get Alert | |
| 02/02/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 21.95% | $745 → $800 | Maintains | Equal-Weight | Get Alert | |
| 01/05/2026 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.70 | 35.14% | $3 → $5 | Maintains | Equal-Weight | Get Alert | |
| 12/16/2025 | MIST | Buy Now | Milestone Pharmaceuticals | $1.17 | 586.11% | $4 → $8 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | LLY | Buy Now | Eli Lilly | $1.20K | 0.25% | $1100 → $1200 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | -11.28% | $53 → $55 | Maintains | Equal-Weight | Get Alert | |
| 12/10/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | 7.74% | $460 → $515 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 13.57% | $700 → $745 | Maintains | Equal-Weight | Get Alert | |
| 12/10/2025 | GILD | Buy Now | Gilead Sciences | $129.98 | 15.4% | $145 → $150 | Maintains | Overweight | Get Alert | |
| 12/10/2025 | BIIB | Buy Now | Biogen | $201.80 | -5.85% | $155 → $190 | Maintains | Equal-Weight | Get Alert | |
| 12/10/2025 | AMGN | Buy Now | Amgen | $376.34 | -13.64% | $300 → $325 | Maintains | Equal-Weight | Get Alert | |
| 11/24/2025 | MRK | Buy Now | Merck & Co | $130.41 | -4.15% | $90 → $125 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 11/20/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 6.71% | $615 → $700 | Maintains | Equal-Weight | Get Alert | |
| 11/18/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | -7.43% | $170 → $235 | Maintains | Overweight | Get Alert | |
| 11/11/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.70 | -18.92% | $1 → $3 | Maintains | Equal-Weight | Get Alert | |
| 11/11/2025 | MLYS | Buy Now | Mineralys Therapeutics | $26.82 | 105.07% | $50 → $55 | Maintains | Overweight | Get Alert | |
| 11/05/2025 | AMGN | Buy Now | Amgen | $376.34 | -20.28% | $280 → $300 | Maintains | Overweight | Get Alert | |
| 10/31/2025 | GILD | Buy Now | Gilead Sciences | $129.98 | 11.56% | $140 → $145 | Maintains | Overweight | Get Alert | |
| 10/29/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | -6.25% | $580 → $615 | Maintains | Equal-Weight | Get Alert | |
| 10/28/2025 | BMRN | Buy Now | BioMarin Pharmaceutical | $59.50 | 17.65% | $90 → $70 | Maintains | Overweight | Get Alert | |
| 09/12/2025 | ABBV | Buy Now | AbbVie | $258.05 | 0.76% | $240 → $260 | Maintains | Overweight | Get Alert | |
| 09/11/2025 | TVTX | Buy Now | Travere Therapeutics | $55.25 | -36.65% | $27 → $35 | Maintains | Overweight | Get Alert | |
| 09/11/2025 | MLYS | Buy Now | Mineralys Therapeutics | $26.82 | 86.43% | $26 → $50 | Maintains | Overweight | Get Alert | |
| 09/11/2025 | MIST | Buy Now | Milestone Pharmaceuticals | $1.17 | 243.05% | → $4 | Initiates | → Overweight | Get Alert | |
| 08/06/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -3.76% | $460 → $460 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 08/05/2025 | BNTX | Buy Now | BioNTech | $89.50 | 67.6% | $170 → $150 | Maintains | Overweight | Get Alert | |
| 07/30/2025 | MRK | Buy Now | Merck & Co | $130.41 | -30.98% | $97 → $90 | Maintains | Equal-Weight | Get Alert | |
| 05/30/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | -11.59% | $700 → $580 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 05/13/2025 | XENE | Buy Now | Xenon Pharmaceuticals | $65.42 | -28.16% | $50 → $47 | Maintains | Overweight | Get Alert | |
| 05/07/2025 | HALO | Buy Now | Halozyme Therapeutics | $82.00 | -20.73% | $60 → $65 | Maintains | Equal-Weight | Get Alert | |
| 04/30/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 6.71% | $750 → $700 | Maintains | Overweight | Get Alert | |
| 04/28/2025 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | -14.5% | $62 → $53 | Maintains | Equal-Weight | Get Alert | |
| 04/15/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.70 | -72.97% | $7 → $1 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/05/2025 | LLY | Buy Now | Eli Lilly | $1.20K | -8.1% | $970 → $1100 | Maintains | Overweight | Get Alert | |
| 03/05/2025 | GILD | Buy Now | Gilead Sciences | $129.98 | 7.71% | $120 → $140 | Maintains | Overweight | Get Alert | |
| 03/05/2025 | ABBV | Buy Now | AbbVie | $258.05 | -6.99% | $210 → $240 | Maintains | Overweight | Get Alert | |
| 02/13/2025 | BIIB | Buy Now | Biogen | $201.80 | -30.62% | $165 → $140 | Maintains | Equal-Weight | Get Alert | |
| 02/13/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | -33.04% | $130 → $170 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 02/12/2025 | GILD | Buy Now | Gilead Sciences | $129.98 | -7.68% | $105 → $120 | Maintains | Overweight | Get Alert | |
| 02/07/2025 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | 0.02% | $60 → $62 | Maintains | Equal-Weight | Get Alert | |
| 02/03/2025 | ABBV | Buy Now | AbbVie | $258.05 | -18.62% | $195 → $210 | Maintains | Overweight | Get Alert | |
| 01/30/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -3.76% | $460 → $460 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 01/28/2025 | LLY | Buy Now | Eli Lilly | $1.20K | -18.96% | $1000 → $970 | Maintains | Overweight | Get Alert | |
| 01/13/2025 | HALO | Buy Now | Halozyme Therapeutics | $82.00 | -30.49% | $62 → $57 | Maintains | Equal-Weight | Get Alert | |
| 01/10/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -3.76% | $555 → $460 | Maintains | Overweight | Get Alert | |
| 01/10/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 37.19% | $1050 → $900 | Maintains | Overweight | Get Alert | |
| 01/10/2025 | BIIB | Buy Now | Biogen | $201.80 | -18.24% | $190 → $165 | Maintains | Equal-Weight | Get Alert | |
| 01/10/2025 | AMGN | Buy Now | Amgen | $376.34 | -25.6% | $335 → $280 | Maintains | Equal-Weight | Get Alert | |
| 12/11/2024 | SMMT | Buy Now | Summit Therapeutics | $13.66 | 119.62% | → $30 | Initiates | → Overweight | Get Alert | |
| 12/11/2024 | BNTX | Buy Now | BioNTech | $89.50 | 89.94% | → $170 | Initiates | → Overweight | Get Alert | |
| 11/21/2024 | VERA | Buy Now | Vera Therapeutics | $35.50 | 97.18% | → $70 | Initiates | → Overweight | Get Alert | |
| 11/18/2024 | ABBV | Buy Now | AbbVie | $258.05 | -24.43% | $205 → $195 | Maintains | Overweight | Get Alert | |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $129.98 | -19.22% | $100 → $105 | Maintains | Overweight | Get Alert | |
| 11/01/2024 | MRK | Buy Now | Merck & Co | $130.41 | -15.65% | $125 → $110 | Maintains | Equal-Weight | Get Alert | |
| 10/31/2024 | BIIB | Buy Now | Biogen | $201.80 | -5.85% | $225 → $190 | Maintains | Equal-Weight | Get Alert | |
| 10/22/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 60.06% | $1200 → $1050 | Maintains | Overweight | Get Alert | |
| 10/21/2024 | TVTX | Buy Now | Travere Therapeutics | $55.25 | -51.13% | $9 → $27 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 10/07/2024 | HALO | Buy Now | Halozyme Therapeutics | $82.00 | -24.39% | $58 → $62 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 10/07/2024 | GILD | Buy Now | Gilead Sciences | $129.98 | -23.07% | $78 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 09/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 82.92% | $1200 → $1200 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/17/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.50 | 51.26% | $115 → $90 | Maintains | Overweight | Get Alert | |
| 08/09/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.70 | 224.32% | $14 → $12 | Maintains | Overweight | Get Alert | |
| 08/09/2024 | LLY | Buy Now | Eli Lilly | $1.20K | -16.46% | $875 → $1000 | Maintains | Overweight | Get Alert | |
| 08/07/2024 | AMGN | Buy Now | Amgen | $376.34 | -10.98% | $320 → $335 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/02/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 82.92% | $1125 → $1200 | Maintains | Overweight | Get Alert | |
| 08/02/2024 | BIIB | Buy Now | Biogen | $201.80 | 11.5% | $240 → $225 | Maintains | Equal-Weight | Get Alert | |
| 08/01/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | -52.73% | $140 → $120 | Maintains | Equal-Weight | Get Alert | |
| 07/31/2024 | PFE | Buy Now | Pfizer | $24.55 | 22.2% | $28 → $30 | Maintains | Equal-Weight | Get Alert | |
| 07/31/2024 | MRK | Buy Now | Merck & Co | $130.41 | -4.15% | $140 → $125 | Maintains | Equal-Weight | Get Alert | |
| 07/26/2024 | ABBV | Buy Now | AbbVie | $258.05 | -20.56% | $200 → $205 | Maintains | Overweight | Get Alert | |
| 06/27/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.50 | 93.28% | $110 → $115 | Maintains | Overweight | Get Alert | |
| 06/24/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | 16.11% | $540 → $555 | Maintains | Overweight | Get Alert | |
| 06/07/2024 | HALO | Buy Now | Halozyme Therapeutics | $82.00 | -29.27% | $48 → $58 | Maintains | Overweight | Get Alert | |
| 04/25/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.50 | 84.87% | $100 → $110 | Maintains | Overweight | Get Alert | |
| 04/24/2024 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | -3.28% | $140 → $170 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 04/18/2024 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | -16.12% | $51 → $52 | Maintains | Equal-Weight | Get Alert | |
| 03/27/2024 | MRK | Buy Now | Merck & Co | $130.41 | 3.52% | $130 → $135 | Maintains | Equal-Weight | Get Alert | |
| 03/04/2024 | GILD | Buy Now | Gilead Sciences | $129.98 | -39.99% | $84 → $78 | Maintains | Equal-Weight | Get Alert | |
| 03/01/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.70 | 278.38% | $20 → $14 | Maintains | Overweight | Get Alert | |
| 02/16/2024 | TVTX | Buy Now | Travere Therapeutics | $55.25 | -83.71% | $8 → $9 | Maintains | Equal-Weight | Get Alert | |
| 02/14/2024 | BIIB | Buy Now | Biogen | $201.80 | 18.93% | $315 → $240 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 02/08/2024 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | -20.35% | $127 → $140 | Maintains | Equal-Weight | Get Alert | |
| 02/07/2024 | LLY | Buy Now | Eli Lilly | $1.20K | -31.08% | $700 → $825 | Maintains | Overweight | Get Alert | |
| 02/07/2024 | GILD | Buy Now | Gilead Sciences | $129.98 | -35.37% | $90 → $84 | Maintains | Equal-Weight | Get Alert | |
| 02/06/2024 | LLY | Buy Now | Eli Lilly | $1.20K | -31.08% | $700 → $825 | Maintains | Overweight | Get Alert | |
| 02/06/2024 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | -17.73% | $58 → $51 | Maintains | Equal-Weight | Get Alert | |
| 02/06/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | 12.97% | $500 → $540 | Maintains | Overweight | Get Alert | |
| 02/05/2024 | ABBV | Buy Now | AbbVie | $258.05 | -22.5% | $180 → $200 | Maintains | Overweight | Get Alert | |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $130.41 | -0.31% | $125 → $130 | Maintains | Equal-Weight | Get Alert | |
| 01/24/2024 | LLY | Buy Now | Eli Lilly | $1.20K | -41.52% | $650 → $700 | Maintains | Overweight | Get Alert | |
| 01/02/2024 | ABBV | Buy Now | AbbVie | $258.05 | -30.25% | $195 → $180 | Maintains | Overweight | Get Alert | |
| 12/14/2023 | PFE | Buy Now | Pfizer | $24.55 | 14.05% | $35 → $28 | Maintains | Equal-Weight | Get Alert | |
| 12/14/2023 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.70 | 440.54% | → $20 | Initiates | → Overweight | Get Alert | |
| 12/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | -27.75% | $110 → $127 | Maintains | Equal-Weight | Get Alert | |
| 11/09/2023 | BIIB | Buy Now | Biogen | $201.80 | 80.87% | $343 → $365 | Maintains | Overweight | Get Alert | |
| 10/17/2023 | PFE | Buy Now | Pfizer | $24.55 | 42.57% | $39 → $35 | Maintains | Equal-Weight | Get Alert | |
| 10/16/2023 | PFE | Buy Now | Pfizer | $24.55 | 42.57% | $39 → $35 | Maintains | Equal-Weight | Get Alert | |
| 10/12/2023 | AMGN | Buy Now | Amgen | $376.34 | -14.97% | $265 → $320 | Maintains | Overweight | Get Alert | |
| 10/09/2023 | LLY | Buy Now | Eli Lilly | $1.20K | -45.7% | $615 → $650 | Maintains | Overweight | Get Alert | |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $55.25 | -85.52% | $24 → $8 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 49.39% | $875 → $980 | Maintains | Overweight | Get Alert | |
| 08/08/2023 | LLY | Buy Now | Eli Lilly | $1.20K | -48.62% | $500 → $615 | Maintains | Overweight | Get Alert | |
| 08/07/2023 | BIIB | Buy Now | Biogen | $201.80 | 69.97% | $350 → $343 | Maintains | Overweight | Get Alert | |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -11.09% | $410 → $425 | Maintains | Overweight | Get Alert | |
| 08/01/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $30 → $40 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | 4.86% | $78 → $65 | Maintains | Equal-Weight | Get Alert | |
| 05/26/2023 | LLY | Buy Now | Eli Lilly | $1.20K | -58.23% | $440 → $500 | Maintains | Overweight | Get Alert | |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | -37.42% | $115 → $110 | Maintains | Equal-Weight | Get Alert | |
| 05/04/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | → $30 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 05/02/2023 | TVTX | Buy Now | Travere Therapeutics | $55.25 | -56.56% | $28 → $24 | Maintains | Overweight | Get Alert | |
| 04/28/2023 | ABBV | Buy Now | AbbVie | $258.05 | -24.43% | $200 → $195 | Maintains | Overweight | Get Alert | |
| 04/28/2023 | LLY | Buy Now | Eli Lilly | $1.20K | -63.24% | $375 → $440 | Maintains | Overweight | Get Alert | |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 39.48% | $860 → $915 | Maintains | Overweight | Get Alert | |
| 03/17/2023 | PFE | Buy Now | Pfizer | $24.55 | 79.23% | $50 → $44 | Maintains | Equal-Weight | Get Alert | |
| 03/17/2023 | HALO | Buy Now | Halozyme Therapeutics | $82.00 | -41.46% | $55 → $48 | Maintains | Overweight | Get Alert | |
| 03/16/2023 | HALO | Buy Now | Halozyme Therapeutics | $82.00 | -32.93% | $65 → $55 | Maintains | Overweight | Get Alert | |
| 03/13/2023 | MRK | Buy Now | Merck & Co | $130.41 | -11.81% | $120 → $115 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/13/2023 | LLY | Buy Now | Eli Lilly | $1.20K | -68.67% | $360 → $375 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 03/13/2023 | AMGN | Buy Now | Amgen | $376.34 | -29.58% | $275 → $265 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $26.82 | 0.67% | → $27 | Initiates | → Overweight | Get Alert | |
| 02/23/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | $38 → $30 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 02/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 31.1% | $800 → $860 | Maintains | Overweight | Get Alert | |
| 02/17/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 31.1% | $800 → $860 | Maintains | Overweight | Get Alert | |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | -34.57% | $120 → $115 | Maintains | Equal-Weight | Get Alert | |
| 02/03/2023 | MRK | Buy Now | Merck & Co | $130.41 | -7.98% | $125 → $120 | Maintains | Overweight | Get Alert | |
| 02/03/2023 | LLY | Buy Now | Eli Lilly | $1.20K | -69.92% | $375 → $360 | Maintains | Equal-Weight | Get Alert | |
| 02/01/2023 | AMGN | Buy Now | Amgen | $376.34 | -26.93% | $285 → $275 | Maintains | Equal-Weight | Get Alert | |
| 01/17/2023 | PFE | Buy Now | Pfizer | $24.55 | 103.67% | $54 → $50 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 01/03/2023 | MRK | Buy Now | Merck & Co | $130.41 | -4.15% | $110 → $125 | Maintains | Overweight | Get Alert | |
| 01/03/2023 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | 25.83% | $70 → $78 | Maintains | Equal-Weight | Get Alert | |
| 01/03/2023 | GILD | Buy Now | Gilead Sciences | $129.98 | -30.76% | $75 → $90 | Maintains | Equal-Weight | Get Alert | |
| 01/03/2023 | AMGN | Buy Now | Amgen | $376.34 | -24.27% | $250 → $285 | Maintains | Equal-Weight | Get Alert | |
| 12/08/2022 | LLY | Buy Now | Eli Lilly | $1.20K | -68.67% | $365 → $375 | Maintains | Equal-Weight | Get Alert | |
| 11/28/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $65.42 | -23.57% | → $50 | Initiates | → Overweight | Get Alert | |
| 11/28/2022 | HALO | Buy Now | Halozyme Therapeutics | $82.00 | -20.73% | → $65 | Initiates | → Overweight | Get Alert | |
| 11/02/2022 | PFE | Buy Now | Pfizer | $24.55 | 119.96% | $55 → $54 | Maintains | Overweight | Get Alert | |
| 11/02/2022 | LLY | Buy Now | Eli Lilly | $1.20K | -69.51% | $305 → $365 | Maintains | Equal-Weight | Get Alert | |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | -31.73% | $110 → $120 | Maintains | Equal-Weight | Get Alert | |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $130.41 | -15.65% | $105 → $110 | Maintains | Overweight | Get Alert | |
| 10/28/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -29.91% | $305 → $335 | Maintains | Overweight | Get Alert | |
| 10/28/2022 | GILD | Buy Now | Gilead Sciences | $129.98 | -42.3% | $74 → $75 | Maintains | Equal-Weight | Get Alert | |
| 09/28/2022 | BIIB | Buy Now | Biogen | $201.80 | 73.44% | $265 → $350 | Maintains | Overweight | Get Alert | |
| 09/26/2022 | NBIX | Buy Now | Neurocrine Biosciences | $175.77 | -37.42% | → $110 | Initiates | → Equal-Weight | Get Alert | |
| 09/26/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | → $38 | Initiates | → Overweight | Get Alert | |
| 09/13/2022 | GILD | Buy Now | Gilead Sciences | $129.98 | -43.07% | $63 → $74 | Maintains | Equal-Weight | Get Alert | |
| 09/12/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 21.95% | $735 → $800 | Maintains | Overweight | Get Alert | |
| 06/03/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 12.04% | $750 → $735 | Maintains | Overweight | Get Alert | |
| 05/17/2022 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | 12.92% | $65 → $70 | Maintains | Equal-Weight | Get Alert | |
| 05/06/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -36.19% | $300 → $305 | Maintains | Overweight | Get Alert | |
| 05/04/2022 | PFE | Buy Now | Pfizer | $24.55 | 124.03% | $60 → $55 | Maintains | Overweight | Get Alert | |
| 05/02/2022 | ABBV | Buy Now | AbbVie | $258.05 | -22.5% | $165 → $200 | Maintains | Overweight | Get Alert | |
| 04/29/2022 | MRK | Buy Now | Merck & Co | $130.41 | -19.48% | $90 → $105 | Maintains | Overweight | Get Alert | |
| 04/29/2022 | LLY | Buy Now | Eli Lilly | $1.20K | -74.52% | $280 → $305 | Maintains | Equal-Weight | Get Alert | |
| 04/18/2022 | BIIB | Buy Now | Biogen | $201.80 | 31.32% | $235 → $265 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 04/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -37.24% | $270 → $300 | Maintains | Overweight | Get Alert | |
| 03/22/2022 | GILD | Buy Now | Gilead Sciences | $129.98 | -51.53% | $70 → $63 | Maintains | Equal-Weight | Get Alert | |
| 03/02/2022 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | 4.86% | $60 → $65 | Maintains | Equal-Weight | Get Alert | |
| 02/09/2022 | AMGN | Buy Now | Amgen | $376.34 | -33.57% | $210 → $250 | Maintains | Equal-Weight | Get Alert | |
| 02/04/2022 | BIIB | Buy Now | Biogen | $201.80 | 16.45% | $284 → $235 | Maintains | Equal-Weight | Get Alert | |
| 01/07/2022 | PFE | Buy Now | Pfizer | $24.55 | 164.77% | $60 → $65 | Maintains | Overweight | Get Alert | |
| 01/04/2022 | LLY | Buy Now | Eli Lilly | $1.20K | -76.61% | $270 → $280 | Maintains | Equal-Weight | Get Alert | |
| 12/09/2021 | ABBV | Buy Now | AbbVie | $258.05 | -36.06% | → $165 | Initiates | → Overweight | Get Alert | |
| 12/09/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | 14.33% | → $750 | Initiates | → Overweight | Get Alert | |
| 12/09/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -43.51% | → $270 | Initiates | → Overweight | Get Alert | |
| 12/09/2021 | MRK | Buy Now | Merck & Co | $130.41 | -30.98% | → $90 | Initiates | → Overweight | Get Alert | |
| 12/09/2021 | BIIB | Buy Now | Biogen | $201.80 | 23.89% | → $250 | Initiates | → Equal-Weight | Get Alert | |
| 12/09/2021 | PFE | Buy Now | Pfizer | $24.55 | 144.4% | → $60 | Initiates | → Overweight | Get Alert | |
| 12/09/2021 | BMY | Buy Now | Bristol-Myers Squibb | $61.99 | -6.44% | → $58 | Initiates | → Equal-Weight | Get Alert | |
| 12/09/2021 | AMGN | Buy Now | Amgen | $376.34 | -44.2% | → $210 | Initiates | → Equal-Weight | Get Alert | |
| 12/09/2021 | GILD | Buy Now | Gilead Sciences | $129.98 | -44.61% | → $72 | Initiates | → Equal-Weight | Get Alert | |
| 12/09/2021 | LLY | Buy Now | Eli Lilly | $1.20K | -77.44% | → $270 | Initiates | → Equal-Weight | Get Alert | |
| 06/11/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $477.99 | -40.38% | $325 → $285 | Maintains | Buy | Get Alert | |
| 06/08/2021 | BIIB | Buy Now | Biogen | $201.80 | 118.04% | $200 → $440 | Upgrade | Sell → Neutral | Get Alert | |
| 06/04/2021 | NMTR | Buy Now | 9 Meters Biopharma | — | — | → $3 | Initiates | → Buy | Get Alert | |
| 03/26/2021 | FBRX | Buy Now | Forte Biosciences | $54.00 | 38.89% | → $75 | Initiates | → Buy | Get Alert | |
| 02/03/2021 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $35 | Initiates | → Buy | Get Alert | |
| 01/14/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | -10.98% | $575 → $584 | Maintains | Buy | Get Alert | |
| 01/07/2021 | RDUS | Buy Now | Radius Health | — | — | $25 → $30 | Maintains | Buy | Get Alert | |
| 12/15/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | → $175 | Downgrade | Buy → Neutral | Get Alert | |
| 11/03/2020 | STTK | Buy Now | Shattuck Labs | $7.52 | 378.72% | → $36 | Initiates | → Buy | Get Alert | |
| 10/06/2020 | MYOK | Buy Now | MyoKardia | — | — | $125 → $225 | Downgrade | Buy → Neutral | Get Alert | |
| 08/20/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.50 | 44.54% | $148 → $86 | Downgrade | Buy → Neutral | Get Alert | |
| 08/11/2020 | RDUS | Buy Now | Radius Health | — | — | $39 → $25 | Maintains | Buy | Get Alert | |
| 08/06/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | -3.2% | $585 → $635 | Maintains | Neutral | Get Alert | |
| 05/12/2020 | MYOK | Buy Now | MyoKardia | — | — | $87 → $125 | Maintains | Buy | Get Alert | |
| 05/01/2020 | AMGN | Buy Now | Amgen | $376.34 | -37.02% | $220 → $237 | Maintains | Equal-Weight | Get Alert | |
| 04/30/2020 | AVTR | Buy Now | Avantor | $11.44 | 66.08% | $16 → $19 | Maintains | Buy | Get Alert | |
| 04/28/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | -12.35% | $540 → $575 | Downgrade | Buy → Neutral | Get Alert | |
| 04/27/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $8 → $5 | Maintains | Buy | Get Alert | |
| 03/27/2020 | CALA | Buy Now | Calithera Biosciences | $0.00 | 2333233.33% | $8 → $7 | Maintains | Buy | Get Alert | |
| 03/20/2020 | AVTR | Buy Now | Avantor | $11.44 | -3.85% | $22 → $11 | Maintains | Buy | Get Alert | |
| 02/06/2020 | BIIB | Buy Now | Biogen | $201.80 | 54.11% | $286 → $311 | Maintains | Equal-Weight | Get Alert | |
| 12/20/2019 | MYOK | Buy Now | MyoKardia | — | — | $70 → $87 | Maintains | Buy | Get Alert | |
| 12/03/2019 | BOLD | Buy Now | Audentes Therapeutics | $2.45 | 2345.59% | $30 → $60 | Upgrade | Sell → Neutral | Get Alert | |
| 11/07/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $656.01 | -35.98% | $340 → $420 | Upgrade | Neutral → Buy | Get Alert | |
| 10/30/2019 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.50 | 59.66% | $120 → $95 | Maintains | Buy | Get Alert | |
| 08/29/2019 | RDUS | Buy Now | Radius Health | — | — | $24 → $40 | Upgrade | Neutral → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved